About Alzamend Neuro (ALZN)
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic ... Read more
- USD3.53
- USD3.55
- USD3.45
- USD135.54
- -42.40%
- --
- 48.00
- 372.12k
- 3M
- 3.06
- -93.80%
Stock News
2 hours ago
Bitcoin tops $110,000: Why the milestones keep coming
MarketWatch
6 hours ago
PDO Vs. PDI: Hold PDO Amid U.S. Credit Rating Downgrade
SeekingAlpha
7 hours ago
Credit Downgrade: Markets Poised To Shake It Off
SeekingAlpha
8 hours ago
The Private Market's Burgeoning Influence On MLP Valuations
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
